Federal award
EAGLE PHARMACEUTICALS, INC.
SPE2D024F0108
Contract
Obligated and Ceiling
- Obligated (net)
- $154,450.85
- Ceiling (potential value, not spending)
- $154,450.85
- Current value
- $154,450.85
- Gross positive obligations
- $154,450.85
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- EAGLE PHARMACEUTICALS, INC. · VRQKPMHD3CK7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- EAGLE PHARMACEUTICALS, INC. · VRQKPMHD3CK7
- Awarding agency
- Department of Defense · sub-agency 97AS · office SPE2D0
- Funding agency
- Department of Defense · sub-agency 97AS
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325411 · MEDICINAL AND BOTANICAL MANUFACTURING
- PIID
- SPE2D024F0108
- Parent vehicle (IDV PIID)
- SPE2D018D0006
- Award type code
- C
- Actions
- 1 · Mar 5, 2024 to Mar 5, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History1
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 5, 2024 | FY2024 | 0 | — | $154,450.85 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.